What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (5 Viewers)

A little surprised at the early strength. I advised my brother and father to get their cost basis out, because it's hard to put a positive spin on the increasing delay.

 
Not sure why but I'm not that concerned right now.  

I'm just trusting the experts at this point.

With no insight at all behind the scenes and a multitude of reasons of why this may be delayed, all I can do is trust the experts and their opinion of the science.

It feels good to be calm.

 
Not sure why but I'm not that concerned right now.  

I'm just trusting the experts at this point.

With no insight at all behind the scenes and a multitude of reasons of why this may be delayed, all I can do is trust the experts and their opinion of the science.

It feels good to be calm.
Expert support doesn't equal clinical trial success. 

We're nearly 2 months out since trial close and no results yet. Seems like they're fishing again. 

 
Expert support doesn't equal clinical trial success. 

We're nearly 2 months out since trial close and no results yet. Seems like they're fishing again. 
Of course it doesn't.   Assuming something bad has happened when you have no visibility into what is going on behind the scenes doesn't make sense to me either though.

They have to report a material event either way. 

 
All my small stock money is tied up in CYDY, feeling resentful watching all of these penny stock plays.
yeah I've thrown considerably less into some of the pennies and have quintupled over the last few weeks.  If I'd have thrown CYDY type funds into those, I'd be feeling like a babychet.

 
To calculate the p-value in the mild-moderate trial, Amarex used Fisher's Exact Test.  I made an Excel sheet to calculate the p-value using Fisher's Exact Test and the results show a statistically significant result with a placebo mortality rate of 26.9% (assuming 90 total deaths).  

Drug 55 deaths / 205 alive

Placebo 35 deaths / 95 alive

P-Value 0.0447

This is outstanding and should make it much easier for CYDY to show a statistically significant result.

 
To calculate the p-value in the mild-moderate trial, Amarex used Fisher's Exact Test.  I made an Excel sheet to calculate the p-value using Fisher's Exact Test and the results show a statistically significant result with a placebo mortality rate of 26.9% (assuming 90 total deaths).  

Drug 55 deaths / 205 alive

Placebo 35 deaths / 95 alive

P-Value 0.0447

This is outstanding and should make it much easier for CYDY to show a statistically significant result.
Were there 400 patients though? Thought it was 390?

 
To calculate the p-value in the mild-moderate trial, Amarex used Fisher's Exact Test.  I made an Excel sheet to calculate the p-value using Fisher's Exact Test and the results show a statistically significant result with a placebo mortality rate of 26.9% (assuming 90 total deaths).  

Drug 55 deaths / 205 alive

Placebo 35 deaths / 95 alive

P-Value 0.0447

This is outstanding and should make it much easier for CYDY to show a statistically significant result.
This seems very doable. I believe those numbers would mean that LL reduces deathrate by 21% over current SOC.

 
Just thought I would introduce myself.  I sold my position after the mother-in-law CC where CEO claimed he treated her stroke with Leronlimab and advised he would share videotape of this at some point, which never happened.  I bought in at an average of 40 cents and thus should be pleased but mad at myself for not selling at the all-time high of $10. 

I’ve followed all the blogs and I admit this is kind of a stock soap opera for me.  I sense some investors are all in with CYDY.  I admit it was difficult for me to make disparaging remarks about CYDY when things were going good but now that I am out, I am very concerned for anyone that has their lifesavings in this.  If the company does not meet their endpoint for COVID, the stock will implode to around a dollar and then from there will go to $0.00 if the BLA for HIV gets rejected for a 3rd time.  I sense something is very wrong with that part of it, as some time has passed.  Could you imagine what would happen to the SP if they have to redo the trials?

I’ve always been very uneasy owning CYDY, as there has been way too much change in management and then there was the breakup with Dr. Pestell and Dr. Patterson.  I was hoping they would get bought out with good COVID numbers along with the BLA being accepted.  That did not happen for mild to moderate.  If they actually had something, would someone not have made an offer or some kind of partnership?  I don’t consider Vyera Pharmaceuticals a sustainable partnership with their murky connections to Martin Shkreli. 

Even if they do get approval for COVID, I suspect there will be competition with HGEN and perhaps EDSA along with AVIR.  I suspect we will hear something this week.  If we do not get a legit PR with perhaps a CC to tune into the following week, you know it will not be good.  If Mrs. Kelly sells before announcement, it will be ugly.  If indeed, Leronlimab can treat everything from HIV to cancer to Nash, why would she want to sell within 3 months?  Why not hold for all the future gains?  I have my doubts Leronlimab can treat cancer.  During the Philippine’s video, the CEO showed a chart showing who lived and died.  I believe there were 3 deaths.  You can live with cancer for many years.  There is way too much promotion with this company.  From the posts I have read, I gather most of you are very much aware of the circus that is CytoDyn.  Good luck.

 
Just thought I would introduce myself.  I sold my position after the mother-in-law CC where CEO claimed he treated her stroke with Leronlimab and advised he would share videotape of this at some point, which never happened.  I bought in at an average of 40 cents and thus should be pleased but mad at myself for not selling at the all-time high of $10. 

I’ve followed all the blogs and I admit this is kind of a stock soap opera for me.  I sense some investors are all in with CYDY.  I admit it was difficult for me to make disparaging remarks about CYDY when things were going good but now that I am out, I am very concerned for anyone that has their lifesavings in this.  If the company does not meet their endpoint for COVID, the stock will implode to around a dollar and then from there will go to $0.00 if the BLA for HIV gets rejected for a 3rd time.  I sense something is very wrong with that part of it, as some time has passed.  Could you imagine what would happen to the SP if they have to redo the trials?

I’ve always been very uneasy owning CYDY, as there has been way too much change in management and then there was the breakup with Dr. Pestell and Dr. Patterson.  I was hoping they would get bought out with good COVID numbers along with the BLA being accepted.  That did not happen for mild to moderate.  If they actually had something, would someone not have made an offer or some kind of partnership?  I don’t consider Vyera Pharmaceuticals a sustainable partnership with their murky connections to Martin Shkreli. 

Even if they do get approval for COVID, I suspect there will be competition with HGEN and perhaps EDSA along with AVIR.  I suspect we will hear something this week.  If we do not get a legit PR with perhaps a CC to tune into the following week, you know it will not be good.  If Mrs. Kelly sells before announcement, it will be ugly.  If indeed, Leronlimab can treat everything from HIV to cancer to Nash, why would she want to sell within 3 months?  Why not hold for all the future gains?  I have my doubts Leronlimab can treat cancer.  During the Philippine’s video, the CEO showed a chart showing who lived and died.  I believe there were 3 deaths.  You can live with cancer for many years.  There is way too much promotion with this company.  From the posts I have read, I gather most of you are very much aware of the circus that is CytoDyn.  Good luck.
Hey Don! Welcome back. 

 
Nobody should have their life savings or full investment portfolio on any one stock. I trust nobody here is in that situation. 

 
If you go on the FB CytoDyn blog, you will get that sense.  I got blocked for making negative comments about CYDY-I suspect.  Yahoo is also a little crazy for CYDY.  I own 50 different positions in my RRSP, TFSA, open plan, and LIRA.

 
If you go on the FB CytoDyn blog, you will get that sense.  I got blocked for making negative comments about CYDY-I suspect.  Yahoo is also a little crazy for CYDY.  I own 50 different positions in my RRSP, TFSA, open plan, and LIRA.
I am concerned about you being concerned.  Vicious circle here.

 
To calculate the p-value in the mild-moderate trial, Amarex used Fisher's Exact Test.  I made an Excel sheet to calculate the p-value using Fisher's Exact Test and the results show a statistically significant result with a placebo mortality rate of 26.9% (assuming 90 total deaths).  

Drug 55 deaths / 205 alive

Placebo 35 deaths / 95 alive

P-Value 0.0447

This is outstanding and should make it much easier for CYDY to show a statistically significant result.
My bad--I made a mistake.  I didn't continue to add the tail risk which changes the number to 37/53 in a 390 person trial to be statistically significant.

 
I'm not Don the guy with the old school football helmet.  You can see my profile on Seeking Alpha.  
Good because he made some wild and unfounded accusations.  

Welcome.  My daughter is a student at Western University and my in-laws live in Komoka.

 
I was leaning Whyatt.
First thought was Whyatt, although I don't think Whyatt ever bought CYDY, unless that part is completely made up which it may be.

There is a lot to refute in the first Baron post.

I'll just focus on Kelly's wife as it makes perfect sense to me that she would sell shares if trial is a success.  It will be a big payday to lock in and it's not like this is all the shares they have.  As far as holding for cancer and Nash, that is years out, I wouldn't expect anyone to not cash in something before that point.

 
Also I am entirely disappointed because when I saw that there was 21 new posts in this thread, I was convinced something material had happened and immediately went to the Cytodyn site for confirmation (alas nothing)

The Baron, a disappointment already.

 
Also I am entirely disappointed because when I saw that there was 21 new posts in this thread, I was convinced something material had happened and immediately went to the Cytodyn site for confirmation (alas nothing)

The Baron, a disappointment already.
Kinda like when I come here and see 20+ posts of you and Don going in circles for the 50th time.

Thanks for the softball.  :D

 
Someone mentioned on another board that FDA approved Leronlimab for OLE and eIND, AFTER having looked at CD12 data.  That's not correct, is it?

 

Users who are viewing this thread

Back
Top